Krka, d. d. (WSE: KRK), valuation on April 27, 2022

Summary

• Stock: Krka, d. d. (WSE: KRK) common equity

• Market cap: €2.80bn

• Rating: Buy

• Price: €89.80

• Target: €126.59

source: S&P Capital IQ

•••

Setting the stage

Krka, d. d., founded in 1954, is a Slovenian generic pharmaceutical manufacturer. The company makes money by developing, producing, marketing, and selling prescription and non-prescription generic drugs in…